Synairgen plc (SYGGF)

OTC • Market Data in USD, Fundamentals in GBP

$0.01

+$0.01

+14.00K%

Last Update: 29 Aug 2025, 00:00

$15.55M

Market Cap

0.00

P/E Ratio (TTM)

—

Forward Dividend Yield

$0.00 - $0.07

52 Week Range

SYGGF Stock Price Chart

Explore Synairgen plc interactive price chart. Choose custom timeframes to analyze SYGGF price movements and trends.

SYGGF Company Profile

Discover essential business fundamentals and corporate details for Synairgen plc (SYGGF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

20 Jul 2020

Employees

36.00

Website

https://www.synairgen.com

CEO

Richard Marsden

Description

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

SYGGF Financial Timeline

Browse a chronological timeline of Synairgen plc corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 25 Jun 2025

Earnings released on 26 Sept 2024

EPS came in at -$0.02 .

Earnings released on 27 Jun 2024

EPS came in at -$0.02 .

Earnings released on 30 Jun 2023

EPS came in at -$0.03 falling short of the estimated -$0.03 by -9.94%.

Earnings released on 31 Dec 2022

EPS came in at -$0.03 .

Earnings released on 30 Jun 2022

EPS came in at -$0.07 .

Earnings released on 31 Dec 2021

EPS came in at -$0.11 .

Earnings released on 30 Jun 2021

EPS came in at -$0.23 .

Earnings released on 31 Dec 2020

EPS came in at -$0.09 .

SYGGF Stock Performance

Access detailed SYGGF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.